ShareValue scores for EXOZ: Valuation 49, Quality 44, Growth 55, Health 48.

eXoZymes, Inc. logo

EXOZ
NASDAQ

eXoZymes, Inc.

$5.17(-5.05%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 17%
Valuation
49
Fair Value
Price vs Value
Quality
44
Moderate
Business Strength
Growth
55
Moderate
Revenue & Earnings
Health
48
Moderate
Financial Stability
Momentum
22
Bearish
Price Trend

Company Details

About

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026